MGP
GILD icon

M&G plc’s Gilead Sciences GILD Stock Holding History

M&G plc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.89M Sell
78,527
-17,230
-18% -$2.27M 0.05% 221
2026
Q1 		$13.3M Sell
95,757
-6,689
-7% -$937K 0.07% 173
2025
Q4 		$12.6M Buy
102,446
+4,942
+5% +$601K 0.06% 196
2025
Q3 		$10.8M Sell
97,504
-6,864
-7% -$780K 0.06% 203
2025
Q2 		$11.6M Sell
104,368
-30,490
-23% -$3.24M 0.06% 179
2025
Q1 		$15.1M Sell
134,858
-14,352
-10% -$1.48M 0.07% 156
2024
Q4 		$13.7M Sell
149,210
-23,358
-14% -$2.1M 0.08% 169
2024
Q3 		$14.5M Buy
172,568
+17,851
+12% +$1.36M 0.05% 170
2024
Q2 		$10.7M Buy
154,717
+57,709
+59% +$3.85M 0.04% 186
2024
Q1 		$7.08M Buy
+97,008
New +$7.46M 0.03% 267

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M&G plc's GILD Position: Q2 2026 in Review

M&G plc reduced its Gilead Sciences (GILD) stake by 18% in Q2 2026, selling an estimated $2.27M and leaving 78,527 shares worth $9.89M. The position accounts for 0.05% of the portfolio, ranked #221.

M&G plc first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.1M in Q1 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • M&G plc held 78,527 shares of Gilead Sciences worth $9.89M as of Q2 2026.
  • M&G plc sold 17,230 Gilead Sciences shares in Q2 2026, an estimated $2.27M.
  • Gilead Sciences made up 0.05% of M&G plc's portfolio in Q2 2026, its #221 holding.
  • M&G plc first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Gilead Sciences position peaked at $15.1M in Q1 2025.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.